Human metapneumovirus: how serious is the threat?
HMPV outbreak in China is unlike Covid-19 and no cause for alarm, say health officials

China is experiencing a surge in infections of a respiratory virus that is especially dangerous for young children, the elderly and vulnerable groups.
Reports of overcrowded hospitals and people wearing masks have prompted comparisons with the outbreak of Covid five years ago, but human metapneumovirus is far from a mystery illness.
What are the symptoms and how is it spread?
Human metapneumovirus, or HMPV, is a respiratory virus with flu-like symptoms that include a cough, fever and fatigue. With an incubation period of between three and six days, it is one of several viruses often lumped together under a broad definition of the "common cold", Dr Jacqueline Stephens, a senior lecturer in public health at Flinders University in Australia, told The Guardian.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A single-stranded RNA virus first identified in the Netherlands in 2001, HMPV is spread through respiratory droplets or contact with contaminated surfaces. It is not, however, a "notifiable disease like Covid-19 or influenza".
The illness is "typically mild", said The Independent, but it can lead to "severe complications such as pneumonia, particularly in infants, the elderly, and those with weakened immune systems".
There is currently no vaccine and treatment is focused on alleviating symptoms.
How dangerous is the new outbreak?
According to a 2021 study, 3%-10% of hospital admissions globally in 2018 and 1% of acute lower respiratory infection-related deaths in children aged under five were attributed to HMPV. The study also found that children under six months, especially those in low- and lower-middle-income countries, are at greater risk of death caused by the HMPV virus.
Beijing has downplayed the virus as an annual winter event. "Respiratory infections tend to peak during the winter season," China's foreign ministry spokesperson Mao Ning said on Friday. The apparent increase in cases is "likely partly due to new technology more easily detecting and identifying HMPV", according to experts who spoke to The Guardian.
The spike in cases "coincides with colder weather and increased indoor activity, conditions that typically fuel the spread of respiratory viruses", said The Independent. But China was "widely criticised for covering up details about the early stages of the Covid outbreak in the central city of Wuhan", said The Times.
Should we be worried in the West?
Unlike Covid-19, which was a completely new disease, HMPV has "been around for several decades and there is a level of immunity in the global population from past infections", said The Guardian.
Nevertheless, neighbouring countries including Cambodia and Taiwan are keeping a close watch on the situation. Indian media is "awash with reports" of an "outbreak" in China, said The Hindu, but health officials have said there is no need for panic as HMPV is "like any other respiratory virus".
In the UK, official data from the Health Security Agency revealed that 4.5% of swabs sent to sentinel labs in the last week of December tested positive for HMPV, with the highest positivity in those aged under five. The trend for HMPV is "increasing slightly", said the agency.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
What is Mark Zuckerberg's net worth?
The Meta magnate's products are a part of billions of lives
By David Faris Published
-
How to get student loan forgiveness
the explainer Four options for paying back (less of!) your federal student loans
By Becca Stanek, The Week US Published
-
Could artificial superintelligence spell the end of humanity?
Talking Points Growing technology is causing growing concern
By Devika Rao, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published